Monosynaptic Tracing with Defective Rabies Virus

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for identifying and monitoring neural connections are labor-intensive and lack specificity, particularly in distinguishing direct connections from indirect ones, as traditional transsynaptic tracers cross multiple synapses at different rates, leading to ambiguity in labeling neurons connected to a primary neuron or population.

Innovation Solution

The use of defective rabies viruses, such as SADΔG-EGFP, that are engineered to spread monosynaptically, allowing for the expression of detectable proteins like EGFP only in neurons directly connected to the primary neuron, through in situ complementation and pseudotyping with foreign envelope proteins, enabling precise labeling and manipulation of neural networks.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional transsynaptic tracers are used to label connected neurons, then neurons synaptically connected to primary neurons can be identified, but the tracers cross multiple synapses at different rates causing ambiguity in distinguishing direct connections from indirect ones

Engineering Contradiction:
Improveprecision of identifying direct synaptic connectionsVSAvoidambiguity in connection specificity
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The invention segments the transsynaptic tracing process into two distinct stages: first, a retrograde tracer is introduced to label primary neurons; second, a monosynaptic tracer is introduced that can only cross one synapse to label directly connected neurons. This segmentation eliminates the ambiguity of traditional single-stage tracers that cross multiple synapses at different rates, allowing precise identification of direct connections versus indirect connections.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses an intermediary approach by employing two different tracer molecules with distinct properties. The first tracer (retrograde tracer) serves as an intermediary to identify primary neurons, while the second tracer (monosynaptic tracer) acts as a mediator that can only cross one synapse. This intermediary two-step process resolves the information loss about connection specificity that occurs with traditional single-tracer methods.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If labor-intensive methods such as light microscopy or electron microscopy are used to examine neural tissue sections, then detailed neural connections can be visualized, but the process is extremely time-consuming and cannot identify connections of single cells

Engineering Contradiction:
Improvedetection capability of neural connectionsVSAvoidtime required for analysis
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The invention applies self-service by using tracer molecules that automatically label neurons based on their connectivity without requiring manual examination. The tracers self-propagate through synapses and accumulate in connected neurons, providing automatic identification of neural connections. This eliminates the need for labor-intensive microscopy and manual tracing, dramatically reducing analysis time while maintaining detection capability.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The invention replaces the mechanical system of manual microscopy and image analysis with a chemical/biological system. Instead of manually examining tissue sections under microscopes, the method uses tracer molecules that chemically label connected neurons in vivo. This substitution of mechanical examination with biochemical labeling automates the process and enables identification of single-cell connections that would be impractical to analyze manually.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Measurement precision

If photostimulation-based mapping methods are used to identify connections in brain slices, then connection patterns can be revealed, but the methods cannot identify connections of single cells and require extensive manual mapping

Engineering Contradiction:
Improvemapping resolution of neural connectionsVSAvoidcomplexity of mapping procedure
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention uses self-service by employing tracer molecules that automatically map neural connections without requiring complex photostimulation equipment or manual mapping procedures. The tracers self-propagate through the neural circuitry and naturally accumulate in connected neurons, providing automatic high-resolution mapping. This eliminates the device complexity and procedural complexity of photostimulation-based methods while achieving superior single-cell resolution.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS8334095B2Compositions and methods for monosynaptic transport
Publication Date: 2012.12.18 SALK INST FOR BIOLOGICAL STUDIES
  • US8334095B2 patent drawing
  • US8334095B2 patent drawing
  • US8334095B2 patent drawing

AI summary

Disclosed herein are methods of expressing a heterologous nucleic acid sequence, such as a sequence encoding a detectable protein, in a primary neuron (or plurality of primary neurons) and other neurons that are monosynaptically connected to the primary neuron (or plurality of primary neurons). Such methods involve viruses (such as, rabies viruses) defective for transsynaptic transport (TST-defective virus) and in situ complementation of the defect in a manner that permits only monosynaptic transport of the TST-defective virus. The TST-defective virus and, therefore, any heterologous nucleic acid sequence it carries in its genome, are not transmitted to neurons that are not monosynaptically connected to the primary neuron (or plurality of primary neurons). Also disclosed are methods of targeting a TST-defective virus to a genetically defined primary neuron (or plurality of primary neurons). The disclosed technology enables far more specific labelling and/or manipulation of neural networks than has previously been possible.